Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Samiotaki

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
International Journal of Cancer|December 18, 2001
C-MYC and IGF-II mRNA-binding protein (CRD-BP/IMP-1) in benign and malignant mesenchymal tumorsP Ioannidis, T Trangas, E Dimitriadis, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 8, 2019
Cellular Vesicles: New Insights in Engineering Methods, Interaction with Cells and Potential for Brain TargetingA Marazioti, K Papadia, M Kannavou, et al.
Biochimie|February 21, 2006
Autoantibodies against aggrecan in systemic rheumatic diseasesD H Vynios, I Tsagaraki, G H A Grigoreas, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
International Journal of Cancer|December 18, 2001
C-MYC and IGF-II mRNA-binding protein (CRD-BP/IMP-1) in benign and malignant mesenchymal tumorsP Ioannidis, T Trangas, E Dimitriadis, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 8, 2019
Cellular Vesicles: New Insights in Engineering Methods, Interaction with Cells and Potential for Brain TargetingA Marazioti, K Papadia, M Kannavou, et al.
Biochimie|February 21, 2006
Autoantibodies against aggrecan in systemic rheumatic diseasesD H Vynios, I Tsagaraki, G H A Grigoreas, et al.
Pageof 2